Azurebio Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
Azurebio General Information
Description
Provider of medical devices intended to facilitate human health by incorporating discoveries in biomaterials into clinical practice. The company's medical devices offer drug formulation services in development of lyophilisates and liquid formulations of small molecules, peptides, proteins and vaccines, enabling patients to get restoration therapies for bone defects in periodontology, implantology and maxillofacial surgery.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Devices and Supplies
Primary Office
- C Ronda de Poniente 16
- Bajo L, Tres Cantos
- 28760 Madrid
- Spain
Azurebio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Nov-2016 | 00.000 | Completed | Out of Business | ||
| 2. Early Stage VC | 10-May-2011 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 1. Debt - General | 01-May-2011 | $507K | $507K | Completed | Generating Revenue |
Azurebio Patents
Azurebio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2715853-A1 | Devices for the administration of drugs and vaccines in the form of injectable needles | Inactive | 18-Feb-2008 | 00000000000 | |
| EP-2254625-A1 | Devices for the administration of drugs and vaccines in the form of injectable needles | Active | 18-Feb-2008 | 00000000000 | |
| EP-2254625-B1 | Devices for the administration of drugs and vaccines in the form of injectable needles | Inactive | 18-Feb-2008 | 00000000000 | |
| ES-2551940-T3 | Devices for administering medications and vaccines in the form of injectable needles | Active | 18-Feb-2008 | 00000000000 | |
| JP-2011517287-A | Device for administering injectable needle-shaped drugs and vaccines | Pending | 18-Feb-2008 | A61M37/0069 |
Azurebio Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Arcadio Castro Ph.D | Co-Founder, Director & Chief Executive Officer |
Azurebio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
